Opinion
Pharmaceutical Technology on MSNOpinion
Anthropic debuts AI-driven pharma R&D tool, Claude Science
Claude Science launches as big tech companies increasingly eye expansion in the wider healthcare space.
Digital engineering practices improve data accessibility and traceability while preparing life science organizations for ...
When researchers screen potential tuberculosis drugs, they often end up with too many options. Some look promising but later ...
Imagine an official in India facing a public health crisis, say a new variant of the often-deadly Nipah virus cropping up in clinics. A new vaccine could help to contain the outbreak, but developing ...
A model may perform exceptionally well and still lack the evidence package necessary to support regulatory review.
Anthropic will start an internal drug discovery program, part of a new push to sell artificial intelligence tools to drugmakers.
Large language models (LLMs) are gradually transforming research in the life sciences in ways that extend far beyond ...
Anthropic has launched Claude Science, an AI-powered research workspace designed to streamline scientific workflows and data analysis.
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Artificial intelligence has moved from pilot projects to a ...
AI is everywhere in 2026, with the data suggesting adoption rates are surging. According to McKinsey, 65% of professionals now report that their organizations regularly use GenAI, representing a 33% ...
Earlier this month, Judge Rakoff of the Southern District of New York issued a first-of-its-kind ruling in United States v. Heppner. The case involved a criminal defendant, Heppner, who used a public ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results